Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cantor Fitzgerald reaffirmed their overweight rating on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a report issued on Thursday, Benzinga reports. The firm currently has a $21.00 target price on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $120.00 price objective on shares of COMPASS Pathways in a research […]
As the medicinal use of psychedelics gains mainstream attention, fears remain over their effect on mental health and the need for safe administration
CMPS | A complete CMPS overview by MarketWatch. View the latest market news and prices, and trading information.
Shares of COMPASS Pathways plc (CMPS) are up 21% on Wednesday after the company announced that it has entered into a securities purchase agreement for the private placement of up to 16 million ADSs and warrants for the gross proceeds of $284.
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to an additional $160 million...